Xinwei Kuang

761 total citations
10 papers, 169 citations indexed

About

Xinwei Kuang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xinwei Kuang has authored 10 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Xinwei Kuang's work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Xinwei Kuang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Xinwei Kuang collaborates with scholars based in China, Canada and Taiwan. Xinwei Kuang's co-authors include Xiang Chen, Hong Liu, Long Liang, Juan Su, Shuang Zhao, Zhenwei Tang, Jia Guo, Haotian Chen, Cong Peng and Wenrui Ye and has published in prestigious journals such as Nature Communications, Advanced Science and Journal of Medical Internet Research.

In The Last Decade

Xinwei Kuang

7 papers receiving 168 citations

Peers

Xinwei Kuang

MB

ONCOL

IMMUN

EPIDE

PHYSI

Fengtian Li China

Yuchuan Jiang China

Benedikt Agerer Austria

Diane Bruyère Belgium

Annette E. Patterson Canada

Yile Xie China

Katarzyna Parzych United Kingdom

Qihui Wu China

Mohammad Malekan Iran

Fengtian Li China

Xinwei Kuang

179 ×2.6

MB

85 ×1.3

ONCOL

42 ×1.2

IMMUN

28 ×1.1

EPIDE

4 ×0.2

PHYSI

Citations per year, relative to Xinwei Kuang Xinwei Kuang (= 1×) peers Fengtian Li

Countries citing papers authored by Xinwei Kuang

Since Specialization

Citations

This map shows the geographic impact of Xinwei Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinwei Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinwei Kuang more than expected).

Fields of papers citing papers by Xinwei Kuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinwei Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinwei Kuang. The network helps show where Xinwei Kuang may publish in the future.

Co-authorship network of co-authors of Xinwei Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinwei Kuang. A scholar is included among the top collaborators of Xinwei Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinwei Kuang. Xinwei Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Liang, Long, Lin Zhu, Xin Li, et al.. (2025). CD137L promotes immune surveillance in melanoma via HLTF regulation. Nature Communications. 16(1). 8478–8478.

2.

Zhou, Qian, Yuming Sun, Yating Dian, et al.. (2025). Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis. Cell Reports Medicine. 6(10). 102371–102371.

3.

Duan, Shixin, Guo Li, Yi Chu, et al.. (2025). Arginine Metabolic Disruption Impairs Hair Regeneration via ROS‐Mediated Inactivation of mTOR Signaling in Androgenetic Alopecia. Advanced Science. 12(40). e04579–e04579.

4.

Jiang, Zixi, et al.. (2022). Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis. Journal of Medical Internet Research. 24(6). e32728–e32728. 15 indexed citations

5.

Zhu, Lin, Xinwei Kuang, Guanxiong Zhang, et al.. (2022). Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation. Journal for ImmunoTherapy of Cancer. 10(5). e003819–e003819. 23 indexed citations

6.

Liang, Long, Xinwei Kuang, Zuozhong Xie, et al.. (2021). Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo. Journal of Cellular and Molecular Medicine. 25(19). 9228–9240. 20 indexed citations

7.

Li, Hui, Xinwei Kuang, Long Liang, et al.. (2020). The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD‐L1. Advanced Science. 8(2). 2001596–2001596. 45 indexed citations

8.

Tang, Zhenwei, Wenrui Ye, Haotian Chen, et al.. (2019). Role of purines in regulation of metabolic reprogramming. Purinergic Signalling. 15(4). 423–438. 45 indexed citations

9.

Kuang, Xinwei, Min Qi, Cong Peng, et al.. (2017). Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma. Oncotarget. 9(1). 802–811. 20 indexed citations

10.

Zhao, Yue, Wangqing Chen, Wu Zhu, et al.. (2016). Tandem Repeats of TSER Significantly Influence the Efficacy of 5-Fluorouracil in the Treatment of Plantar Warts. Personalized Medicine. 13(3). 233–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact